Pathogenic Mechanisms of Port Wine Stain and Repository of Port Wine Stain Biopsy Samples
1 other identifier
interventional
19
1 country
1
Brief Summary
The purpose of this study is to investigate the pathogenic mechanisms of Port Wine Stain, collect biopsy samples and blood samples to characterize exosomes and metabolites from Port Wine Stain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2013
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 23, 2013
CompletedFirst Submitted
Initial submission to the registry
November 6, 2013
CompletedFirst Posted
Study publicly available on registry
January 31, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 11, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 11, 2019
CompletedNovember 1, 2022
October 1, 2022
5.7 years
November 6, 2013
October 28, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Characterization of Port Wine Stain Birthmark tissue sample
up to 4 weeks
Study Arms (1)
Port Wine Stain Birthmark
OTHERBiopsy sample from Port Wine Stain Birthmark
Interventions
Biopsy sample from Port Wine Stain Birthmark
Eligibility Criteria
You may qualify if:
- Male or female of all ages.
- Not pregnant.
- Has diagnosis of port wine stain on the arms, legs, chest, bac.
- Ability to understand and carry out subject instructions.
- Subject willing to have skin biopsies on port wine stain and normal skin areas.
You may not qualify if:
- Pregnant women.
- Port Wine Stain on the face.
- History of skin cancer.
- Current participation in an investigational drug evaluation
- Concurrent use of known photosensitizing drugs.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beckman Laser Institute
Irvine, California, 92612, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
John s Nelson, MD
Beckman Laser Institute, UCI
- PRINCIPAL INVESTIGATOR
Winbin Tan, PhD
Beckman Laser Institute
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Wenbin Tan, Ph.D. Project Scientist
Study Record Dates
First Submitted
November 6, 2013
First Posted
January 31, 2014
Study Start
April 23, 2013
Primary Completion
January 11, 2019
Study Completion
January 11, 2019
Last Updated
November 1, 2022
Record last verified: 2022-10